La Pitié Hospital Performs its 200th Implant of the World’s Only Approved Total Artificial Heart
Top French Transplant Center Leads World in Total Artificial Heart Implants
TUCSON, Ariz. – Feb. 18, 2010 – On Feb. 18, SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, announced that Groupe hospitalier de la Pitié-Salpétrière (La Pitié) in Paris has performed 200 implants of the Total Artificial Heart, more than any other hospital in the world.
“The SynCardia Total Artificial Heart would not be the clinical success it is today without La Pitié,” said Dr. Jack Copeland, world-renowned Total Artificial Heart pioneer and Chief of Cardiothoracic Surgery at University Medical Center in Tucson, Ariz. “For decades, La Pitié has been a leader in the field of cardiac surgery, performing Europe’s first heart transplant in 1968 and Europe’s first Total Artificial Heart implant in 1986. In December 2009, La Pitié also became the first hospital in the world to use the new Companion Driver System to power the Total Artificial Heart in a patient.”
The La Pitié Department of Cardiac and Thoracic Surgery is led by Prof. Alain Pavie. The 200th implant was performed by Prof. Pascal Leprince on Jan. 5, 2010. Prof. Leprince is a SynCardia proctor who helps train new centers on the Total Artificial Heart and advises them in the operating room during their first implant.
Currently, La Pitié has five Total Artificial Heart patients awaiting heart transplants. The hospital’s 200 implants account for more than 20 patient years of life on the Total Artificial Heart. According to Prof. Pavie, La Pitié has performed more than 2,000 heart transplants, ranking it among the top transplant programs in the world.
About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the SynCardia Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.
Janelle Drumwright, email@example.com, (520) 547-7463